These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

815 related items for PubMed ID: 24107178

  • 1. Advances in adenovirus-mediated p53 cancer gene therapy.
    Tazawa H, Kagawa S, Fujiwara T.
    Expert Opin Biol Ther; 2013 Nov; 13(11):1569-83. PubMed ID: 24107178
    [Abstract] [Full Text] [Related]

  • 2. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
    Horowitz J.
    Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. p53 Replacement Therapy for Cancer.
    Tazawa H, Kagawa S, Fujiwara T.
    Recent Results Cancer Res; 2016 Aug; 209():1-15. PubMed ID: 28101684
    [Abstract] [Full Text] [Related]

  • 5. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M, Sasaki Y, Suzuki H, Mita H, Imai K, Shinomura Y, Tokino T.
    Clin Cancer Res; 2009 Jun 01; 15(11):3725-32. PubMed ID: 19458054
    [Abstract] [Full Text] [Related]

  • 6. Toxicology profiles of a novel p53-armed replication-competent oncolytic adenovirus in rodents, felids, and nonhuman primates.
    Su C, Cao H, Tan S, Huang Y, Jia X, Jiang L, Wang K, Chen Y, Long J, Liu X, Wu M, Wu X, Qian Q.
    Toxicol Sci; 2008 Nov 01; 106(1):242-50. PubMed ID: 18703561
    [Abstract] [Full Text] [Related]

  • 7. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
    Wang H, Wei F, Li H, Ji X, Li S, Chen X.
    Int J Mol Med; 2013 Feb 01; 31(2):377-85. PubMed ID: 23229955
    [Abstract] [Full Text] [Related]

  • 8. Genetically modified adenoviruses against gliomas: from bench to bedside.
    Gomez-Manzano C, Yung WK, Alemany R, Fueyo J.
    Neurology; 2004 Aug 10; 63(3):418-26. PubMed ID: 15304571
    [Abstract] [Full Text] [Related]

  • 9. Key points of basic theories and clinical practice in rAd-p53 ( Gendicine ™) gene therapy for solid malignant tumors.
    Li Y, Li B, Li CJ, Li LJ.
    Expert Opin Biol Ther; 2015 Mar 10; 15(3):437-54. PubMed ID: 25496374
    [Abstract] [Full Text] [Related]

  • 10. Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models.
    Nielsen LL, Gurnani M, Syed J, Dell J, Hartman B, Cartwright M, Johnson RC.
    Hum Gene Ther; 1998 Mar 20; 9(5):681-94. PubMed ID: 9551616
    [Abstract] [Full Text] [Related]

  • 11. Expression of p53, or targeting towards EGFR, enhances the oncolytic potency of conditionally replicative adenovirus against neuroblastoma.
    Geoerger B, van Beusechem VW, Opolon P, Morizet J, Laudani L, Lecluse Y, Barrois M, Idema S, Grill J, Gerritsen WR, Vassal G.
    J Gene Med; 2005 May 20; 7(5):584-94. PubMed ID: 15651070
    [Abstract] [Full Text] [Related]

  • 12. The First Approved Gene Therapy Product for Cancer Ad-p53 (Gendicine): 12 Years in the Clinic.
    Zhang WW, Li L, Li D, Liu J, Li X, Li W, Xu X, Zhang MJ, Chandler LA, Lin H, Hu A, Xu W, Lam DM.
    Hum Gene Ther; 2018 Feb 20; 29(2):160-179. PubMed ID: 29338444
    [Abstract] [Full Text] [Related]

  • 13. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
    Hemmati PG, Gillissen B, von Haefen C, Wendt J, Stärck L, Güner D, Dörken B, Daniel PT.
    Oncogene; 2002 May 09; 21(20):3149-61. PubMed ID: 12082630
    [Abstract] [Full Text] [Related]

  • 14. DNA replication of first-generation adenovirus vectors in tumor cells.
    Steinwaerder DS, Carlson CA, Lieber A.
    Hum Gene Ther; 2000 Sep 01; 11(13):1933-48. PubMed ID: 10986565
    [Abstract] [Full Text] [Related]

  • 15. Late expression of p53 from a replicating adenovirus improves tumor cell killing and is more tumor cell specific than expression of the adenoviral death protein.
    Sauthoff H, Pipiya T, Heitner S, Chen S, Norman RG, Rom WN, Hay JG.
    Hum Gene Ther; 2002 Oct 10; 13(15):1859-71. PubMed ID: 12396618
    [Abstract] [Full Text] [Related]

  • 16. Gene-directed enzyme prodrug therapy with carboxylesterase enhances the anticancer efficacy of the conditionally replicating adenovirus AdDelta24.
    Oosterhoff D, Pinedo HM, Witlox MA, Carette JE, Gerritsen WR, van Beusechem VW.
    Gene Ther; 2005 Jun 10; 12(12):1011-8. PubMed ID: 15729367
    [Abstract] [Full Text] [Related]

  • 17. Development of a novel recombinant adenovirus containing gfp-zeocin fusion expression cassette for conditional replication in p53-deficient human tumor cells.
    Hu B, Joshua MN, Dong C, Qi Y.
    J Virol Methods; 2004 May 10; 117(2):129-36. PubMed ID: 15041209
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy.
    Xie Y, Gilbert JD, Kim JH, Freytag SO.
    Clin Cancer Res; 1999 Dec 10; 5(12):4224-32. PubMed ID: 10632364
    [Abstract] [Full Text] [Related]

  • 19. A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers.
    Wang X, Su C, Cao H, Li K, Chen J, Jiang L, Zhang Q, Wu X, Jia X, Liu Y, Wang W, Liu X, Wu M, Qian Q.
    Mol Cancer Ther; 2008 Jun 10; 7(6):1598-603. PubMed ID: 18566230
    [Abstract] [Full Text] [Related]

  • 20. [Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].
    Zhang SW, Xiao SW, Liu CQ, Sun Y, Su X, Li DM, Xu G, Zhu GY, Xu B.
    Zhonghua Zhong Liu Za Zhi; 2005 Jul 10; 27(7):426-8. PubMed ID: 16188130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.